Detail akcie Crism Therapeutics Corporation online

Business Summary: CRISM Therapeutics Corporation, formerly Amur Minerals Corporation, is a British Virgin Islands-based pharmaceutical company. The Company has developed a drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy. Its lead product, ChemoSeed, is a polymer the size of a grain of rice, administering irinotecan, a generic drug approved to treat brain cancer and can be implanted directly into a tumor or the resection margin following the removal of a tumor, thereby ensuring that effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. It seeks to use ChemoSeed to treat high grade gliomas, a brain tumor with no satisfactory treatment. The Company also offers formulation and consultancy services. It provides assistance and services to improve the bioavailability of poorly soluble drugs. It offers remixers and extruders of various sizes.
Financial Summary: BRIEF: For the six months ended 30 June 2025, CRISM' Therapeutics Corp revenues was not reported. Net loss before extraordinary items increased from L13K to L908K. Higher net loss reflects Administrative and other expenses increase from L300K to L905K (expense), Impairment of loans decrease from L298K (income) to L0K. Basic Earnings per Share excluding Extraordinary Items totaled to -L0.03.